Cognition Therapeutics, Inc. (NASDAQ:CGTX) Short Interest Update
MarketBeat
Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 9,210,000 shares, an increase of 47.8% from the August 15th total of 6,230,000 shares. Currently, 15.6% of the shares of the company are sold short. Based on an average trading volume of 10,600,000 shares, the short-interest ratio is currently 0.9 days. Based on an average trading volume of 10,600,000 shares, the short-interest ratio is currently 0.9 days. Currently, 15.6% of the shares of the company are sold short.
NASDAQ:CGTX